Browse communities
Browse communities
Presenting a webinar?

Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology

Rhenu Bhuller, Mark Dougan
GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
Oct 2 2013
47 mins
Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology
More from this community:

Medical Research

  • Live and recorded (463)
  • Upcoming (21)
  • Date
  • Rating
  • Views
  • This webinar will discuss the evolving role of Cell Lines and Cell Culture and their usefulness as models of physiological function and disease. The webinar will review the depth, breadth and best use of currently available Cell Lines. The role played by Cell Lines in ensuring that the output of future research continues to be valid and credible will also be evaluated. This is the first of a three part webinar series focused on delivering a broad picture of the role of cell lines as models in scientific research, the various strategies and approaches available.
  • Abstract:
    There is a great interest in application of human mesenchymal stem cells (hMSCs) in cell therapy and tissue engineering due to their self-renewal, multi-lineage differentiation, immunomodulation, and trophic potential. One of the challenges faced in the clinical application of hMSCs is the need for efficient expansion of these cells in vitro without altering their capacity. Serum-free mammalian cell culture media, in particular, require optimization of the expansion protocols. Even subtle changes in routine handling can have a significant impact on the cells’ potential.

    This seminar will cover the variables that can influence the desired regenerative and differentiation properties including medium selection, vessel surface treatment, impact of the cell source, and seeding density. We will also discuss how users can select the correct conditions for optimized growth and functionality.

    Speaker Biography:
    Brian Posey is a Product Development Manager for cell culture media at Corning Life Sciences. Brian has over 10 years experience in cell biology and industrial scale cGMP manufacturing of both liquid and powder cell culture media. Since joining Corning in 2012, Brian has lead numerous innovative technology projects for the media business ranging from customer technology transfer for production scale-up to developing new serum-free media for industrial and stem cell lines.
  • Mass spectrometry and other methods such as yeast two-hybrid can now accurately discern protein complexes or larger protein interactomes in diseases such as cancer, yet it is difficult to forward translate this knowledge into human samples. To overcome this hurdle, we began experiments using proximity ligation assays (PLA) to directly translate protein complexes into human tumor materials. Our assay reflects protein complexes between EGFR and GRB2 protein, a key adaptor protein necessary for EGFR pathway activation and coupling to downstream MAPK signaling. We annotated nearly 300 primary xenograft models (PDX) of cancer and show tumor subtype enrichment of EGFR:GRB2 signaling-associated complexes. Furthermore, tumors with abundant levels of EGFR:GRB2 signaling-associated complexes are more likely to respond to anti-EGFR antibody-based therapy. Finally, in 350 lung cancer tissues, across three distinct cohorts of patients, we demonstrate the ability of EGFR:GRB2 protein complexes to segregate tumors and show benefit to EGFR tyrosine kinase inhibitor therapy in patients whose tumors harbor high levels of EGFR:GRB2 signaling-associated complexes. This suggests that annotation of signaling-associated protein complexes in cancer tissues can not only molecularly annotate disease types but may also have predictive capacity for cancer therapeutics. This work opens up the human protein interactome as a new class of molecular markers for disease in a more practical manner. Proteins, encoded by DNA, do not work in isolation but instead function as part of multi-protein complexes that drive both normal and disease physiology. While we demonstrate the utility of this approach in cancer, receptor tyrosine kinase signaling and tyrosine kinase inhibitor therapeutics, our approach described here could have utility across a wide spectrum of both signaling-associated complexes and different types of disease, and thus would be attractive to a large audience.
  • This webinar will discuss the evolving role of Cell Lines and Cell Culture and their usefulness as models of physiological function and disease. The webinar will review the depth, breadth and best use of currently available Cell Lines. The role played by Cell Lines in ensuring that the output of future research continues to be valid and credible will also be evaluated. This is the first of a three part webinar series focused on delivering a broad picture of the role of cell lines as models in scientific research, the various strategies and approaches available.
  • Mass spectrometry and other methods such as yeast two-hybrid can now accurately discern protein complexes or larger protein interactomes in diseases such as cancer, yet it is difficult to forward translate this knowledge into human samples. To overcome this hurdle, we began experiments using proximity ligation assays (PLA) to directly translate protein complexes into human tumor materials. Our assay reflects protein complexes between EGFR and GRB2 protein, a key adaptor protein necessary for EGFR pathway activation and coupling to downstream MAPK signaling. We annotated nearly 300 primary xenograft models (PDX) of cancer and show tumor subtype enrichment of EGFR:GRB2 signaling-associated complexes. Furthermore, tumors with abundant levels of EGFR:GRB2 signaling-associated complexes are more likely to respond to anti-EGFR antibody-based therapy. Finally, in 350 lung cancer tissues, across three distinct cohorts of patients, we demonstrate the ability of EGFR:GRB2 protein complexes to segregate tumors and show benefit to EGFR tyrosine kinase inhibitor therapy in patients whose tumors harbor high levels of EGFR:GRB2 signaling-associated complexes. This suggests that annotation of signaling-associated protein complexes in cancer tissues can not only molecularly annotate disease types but may also have predictive capacity for cancer therapeutics. This work opens up the human protein interactome as a new class of molecular markers for disease in a more practical manner. Proteins, encoded by DNA, do not work in isolation but instead function as part of multi-protein complexes that drive both normal and disease physiology. While we demonstrate the utility of this approach in cancer, receptor tyrosine kinase signaling and tyrosine kinase inhibitor therapeutics, our approach described here could have utility across a wide spectrum of both signaling-associated complexes and different types of disease, and thus would be attractive to a large audience.
  • Today use of the term “single use technologies” can be considered as being synonymous with the modern biotech industries. Based on the proliferation of companies now specialising in providing solutions to pretty much anyone anywhere, along with the intensive level of marketing and industry discussion, it is clear to see that the sector has progressed significantly over the years. The ability to purchase systems and technologies off the shelf as a consumable, rather than invest in significant capital infrastructure, better facilitates small enterprises to perform small and pilot GMP scale manufacture in-house. Organisations are able to leverage the experience of the manufacturers in the development of these products. The concept of single use technologies has been proven to produce solutions which are compliant and work. However, there still are questions around regulatory guidance for single use technologies.
  • Within the development of rapid screening methods to secure the global supply chain, the FDA’s Division of Pharmaceutical Analysis (DPA) has been building Raman spectral libraries for verification of pharmaceutical materials, in conjunction with handheld instruments in the field. Focusing on finished products, we evaluate the spectral library for method specificity, showing high specificity for drugs containing different active ingredients.
  • Visit this page to download our infographic:
    http://www.vitaminsinmotion.com/fileadmin/data/images/infographics/Eat_right_for_your_sight_Digital_06.pdf

    The global market for eye health ingredients is increasing fast with a projected compound growth rate of 5.9% until 2019 [1]. The innovation is no longer focusing only on age-related macular degeneration. Supplementation can be beneficial to healthy people of all ages to achieve optimized visual performance and comfort.

    DSM, Kemin and the University of Georgia have recently published a new study to show how lutein and zeaxanthin supplementation can help younger, healthy people improve their vision, such as the ability to see objects under glare conditions.

    Join our webinar and hear lead author Professor Billy R. Hammond Jr. and DSM’s Jens Birrer and Wolfgang Schalch present the latest findings and explain what the new science means to the market.

    [1] Frost&Sullivan (2013). “Strategic Analysis of the Global Eye Health Ingredients Market”.
  • Channel
  • Channel profile
  • 2015 Healthcare Industry Outlook Recorded: Jan 27 2015 55 mins
    Reenita Das and Venkat Rajan
    The healthcare industry is entangled in a transitory phase where therapeutics, products and services are sold into traditional care settings that are saturated and exhausted. Yet, the opportunities for new services and care, like ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams.

    As a result, Frost & Sullivan’s experts are predicting a year full of big disruptions, transformations and innovations. What’s in store for pharmaceuticals, biotechnology, medical devices, medical imaging, mobile health, healthcare IT, etc.? This briefing will provide an in-depth discussion examining at what degree we can expect the impact to take hold and transpire over the upcoming year.

    Attend this webinar to discover:
    •Insightful analyst predictions and probative analysis of the global healthcare industry in 2015.
    •Key strategies and initiatives executed by companies and organizations to capture opportunities for solutions in health, wellness, and prevention.
    •Track the progress of key macro level industry trends and their projected milestones for 2015.
    •An interactive Q&A session with Frost & Sullivan’s senior industry thought leaders.
  • 2015 Asia Pacific Healthcare Outlook Recorded: Jan 16 2015 110 mins
    Rhenu Bhuller, Natasha Gulati, Dr.Milind Sabnis
    Public and private sector initiatives continue to transform the Healthcare industry in the Asia-Pacific - and their impact is likely to be seen in the coming months. For example, improving access to quality and affordable healthcare is a major goal of governments across the region, and a focus for reform efforts in many countries.

    Frost & Sullivan provides in-depth insights on how impending regulations, ethics and compliance reforms, emerging business and service models and industry partnerships will impact healthcare in the region

    Join us as we examine key trends for 2015 and beyond and discuss their impact on pharmaceuticals, medical devices, health technology, insurance, healthcare delivery and wellness across Asia-Pacific.
  • The Promise of Integrated Healthcare: Health Information Systems Recorded: Jul 31 2014 54 mins
    Bhargav Rajan, Research Analyst
    Given increasing healthcare consumerism and demand for round-the-clock healthcare delivery, hospitals and providers must upgrade their healthcare IT infrastructure to accommodate patient and provider needs. This briefing will investigate the changing technology landscape in hospitals globally and will specifically focus on how hospitals in North America and Europe are adopting health information systems (HIS).

    Attend this webinar to discover:

    ·Information technology systems in hospitals
    ·Drivers and restraints of HIS
    ·A technology and adoption roadmap of HIS
  • Telecommunication Takes On Healthcare Recorded: May 6 2014 47 mins
    Daniel Ruppar, Natasha Gulati, and Shruthi Parakkal
    Telecommunication companies are increasingly seeking new revenue streams by exploring vertical markets like healthcare. Though traditional telecommunication services have achieved strong penetration in the healthcare industry, more sophisticated solutions are only now starting to generate sustainable returns and have a long way to go in terms of enabling a new-age healthcare system. While the industry presents promising opportunities, few telecommunication service providers have been able to establish successful business models in this space.
    Frost & Sullivan will present insights on critical factors that companies overlook while developing their healthcare strategy.

    Attend this webinar to discover:

    •Key success factors necessary for all telecommunication companies establishing a healthcare presence
    •Emerging business models that promise sustainable revenue for leading telecommunication companies in healthcare
  • Healthcare 2020: Disrupt, Transform and Collapse Recorded: Mar 19 2014 57 mins
    Reenita Das, Siddharth Saha, Venkat Rajan, and Natasha Gulati
    Attend this webinar to discover:

    •Changes to healthcare delivery: hospitals of the future, aging in place, cost of care innovations
    •Role of the patient and consumer influence
    •Role of emerging regions as a consumer and competitor
    •Novel industry business models
    •Key disruptive technologies
  • Asia-Pacific Healthcare Outlook 2014 Recorded: Feb 13 2014 44 mins
    Rhenu Bhuller, Reenita Das, and Natasha Gulatii
    Frost & Sullivan will provide an outlook for healthcare in 2014 with detailed insights on the regulatory challenges, investment trends, innovation temperature and emerging business models in the Asia-Pacific Healthcare market.
  • Technology Breakthroughs in Sleep Apnea Recorded: Nov 21 2013 48 mins
    Saju John Mathew, Industry Analyst
    Attend this webinar to discover:

    • Insight into the sleep apneic industry
    • Drivers and restraints of the industry
    • Current trends and technology roadmap
  • Are Biosimilars the Road to Certain Success or a High-Risk Venture? Recorded: Oct 17 2013 45 mins
    Deborah Toscano, Senior Industry Analyst
    Why You Should Attend:

    • Discover the issues involved in regulatory and payer acceptance of biosimilars in the US
    • Learn how biosimilars are forecast to penetrate the various biopharmaceutical segments and therapeutic areas
    • Understand the potential risks and rewards of this market
    • Gain insight into the competitive environment and the potential US market leaders
    • Identify the factors with the potential to impact the uptake of biosimilars
  • 3-D Printing - Healthcare in a Printed World Recorded: Oct 7 2013 34 mins
    Darshana De, Industry Analyst
    With the current advancements in 3-D printing technologies for customized fabrication of complex polymer-based objects, there is much focus on adapting the 3-D printing technologies for healthcare applications. This has aroused interests in engineering bioprinting devices that can develop 3-D structures and at the same time accommodate the incorporation of living cells.

    - The session will discuss the following:
    - The potential of 3-D printing in healthcareD
    - Drivers and challenges for the technology
    - Impact of 3-D printing, scenario melling
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Oct 2 2013 47 mins
    Rhenu Bhuller, Mark Dougan
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • New Era in Revenue Cycle Management Emerges as Healthcare Transforms Recorded: Sep 24 2013 58 mins
    Nancy Fabozzi, Healthcare Principal Analyst
    Why You Should Attend:

    • Learn what RCM is and why it is so important

    • Discover why healthcare providers are increasing their focus on technology solutions to improve end-to-end RCM

    • Review the major disruptive trends in the industry

    • Find out how next-generation technology solutions will help providers streamline and enhance their RCM process
  • Effective Growth Strategies for the Soaring Russian Healthcare Market Recorded: Sep 4 2013 54 mins
    Research Director Siddharth Saha and Senior Consultant Vitaliy Lehkyy
    Attendees will learn about challenges in this diverse marker and pitfalls to avoid; hear about best practices and success stories; and gain insights on effective strategies.

    Why Should You Attend:
    - Learn best practices and what works and does not from the trenches
    - Discover lessons to take from India and China and adopt to Russia
    - Assess specific market opportunities for growth
  • Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology Recorded: Aug 29 2013 49 mins
    Rhenu Bhuller, Mark Dougan
    GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
  • Outlook of Iran and Azerbaijan Healthcare Markets Recorded: Aug 1 2013 36 mins
    Hilal Cura, Research Analyst and Uldouz Berenjforoush, Research Analyst
    This analyst briefing will discuss:

    - High government focus on growth of the healthcare industry and implementing healthcare reforms
    - Growing economies, with their oil-rich and wealthy position
    - Increasing awareness and affluence among their population for healthcare consumption
  • Original Drugs Pave the Way for Follow-on-Biologics Recorded: Jun 18 2013 29 mins
    Sandhya Kamath, Technical Insights Manager
    With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.

    Why you should attend:
    ·Learn about the growth of follow-on-biologics
    ·Identify the drivers and restraints
    ·Discuss trends in technology development
  • Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Recorded: May 15 2013 59 mins
    Reenita Das, Eduardo Golisano, Sandeep Sinha, Xuchao Glenn Hou, and Siddharth Saha
    Attend this webinar to discover:

    ·Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
    ·Common obstacles international companies must overcome in these regions
    ·How to exploit the hidden potential of BRIC countries
    ·Tactics to adjust strategy to successfully penetrate BRIC markets
    ·The top 10 technologies and products expected to drive growth in these regions
  • Global Trends and Transitions Shaping the Future of Medical Imaging Equipment Recorded: Apr 25 2013 39 mins
    Roberto Aranibar, Medical imaging Industry Analyst
    Attend this webinar to discover:

    •Evaluate market potential for basic and advanced medical imaging modalities
    •Learn about important market characteristics and trends
    •Identify opportunities for growth in medical imaging equipment markets within each region of the world
    •Consider factors affecting market growth internationally
  • APAC Market Poised for Electronic Medical Record Growth Recorded: Apr 25 2013 32 mins
    Natasha Gulati, Industry Analyst, Healthcare
    As the healthcare industry across APAC moves toward digitization, electronic health information exchange becomes a stepping stone to success. Governments, non-profit entities and the private sector are aggressively investing in Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems. This Frost & Sullivan briefing presents a comprehensive analysis of the EMR and EHR markets in APAC, with special focus on emerging opportunities in the region.

    Why You Should Attend:
    - Learn about the rapidly developing EMR and EHR markets in APAC
    - Understand key market drivers and restraints
    - Identify leading market participants and their role in the competitive environment
    - Recognize areas of growth within this space
  • Features, Strategies and Promises of Medical Imaging Recorded: Apr 11 2013 24 mins
    Shalena Naidoo, Research Analyst Frost & Sullivan
    Hospital revitalisation initiatives serve as the major driver for improved medical imaging equipment within the public healthcare sector. Growth of the market within the private sector is increasing in proportion to the rapidly emerging technology within the medical imaging space as private healthcare end users try to remain competitive. This briefing will investigate the dynamics of the South African medical imaging market, with specific reference to five key device segments, including, general X-rays, fluoroscopy, mammography, computed tomography (CT) scanners and magnetic resonance imaging (MRI) scanners.
  • 2013 Global Medical Devices Outlook Recorded: Apr 4 2013 52 mins
    Venkat Rajan, Advanced Medical Technologies Industry Manager
    This presentation seeks to highlight:
    - Market projections for the global medical devices market
    - Identification of market sectors and sub-sectors poised for expansion
    - Discussion of key market opportunities in emerging markets
    - Strategies for success in the new market paradigm
Frost & Sullivan Analyst Briefing Series
Through Frost & Sullivan's Healthcare Growth Partnership Services program, clients receive a continuous flow of actionable market, technical, and econometric research, along with applications for growth (our TEAM methodology). Our global team of industry experts continuously monitors the following Healthcare market sectors: pharmaceuticals and biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provides local expertise along with a global perspective.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Next Generation Imaging Informatics: Identifying Unmet Needs in Radiology
  • Live at: Oct 2 2013 3:00 am
  • Presented by: Rhenu Bhuller, Mark Dougan
  • From:
Your email has been sent.
or close
You must be logged in to email this